UFC Anti-Doping Program

Search Medications & Ingredients

Athlete Login >

Medication Search>

Frequently Asked Questions

Answers to your most Frequently Asked Questions. Click a link below to jump to that section.

General | Testing | Whereabouts | Substances | Results Management | Therapeutic Use Exemptions

General

The United States Anti-Doping Agency (USADA) is recognized by the Ultimate Fighting Championship (UFC) as the official, independent anti-doping agency for the UFC. USADA is also recognized by the United States Congress as the official anti-doping organization for all Olympic, Paralympic, Pan American and Para Pan American sport in the United States.

USADA began operations on October 1, 2000 and is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of athletes.

USADA was originally created as the result of recommendations made by the United States Olympic & Paralympic Committee’s Select Task Force on Externalization. Prior to USADA’s founding in October of 2000, management of the anti-doping program for Olympic and Paralympic sport was handled internally by the USOPC. USADA’s creation as a separate and independent entity is unique in major American sport. USADA was established to remove the inherent conflict of interest that results from an organization being charged with both promoting and growing a sport, and handling anti-doping rule violations potentially involving the sport’s elite athletes. The UFC took the important step to externalize their anti-doping program to USADA in June of 2015.

USADA is located in Colorado Springs, Colorado and operates business on the Mountain Time Zone. USADA’s main telephone number is 719-785-2000, and our toll-free telephone number is 1-866-601-2632  (international toll-free: +8008-120-8120. USADA’s main fax number is 719-785-2001. USADA’s general email address is usada@USADA.org. Athletes and their support personnel can contact USADA’s Athlete Express by calling 719-785-2000 or emailing ufcathleteexpress@USADA.org Our mailing address is 5555 Tech Center Drive, Suite 200, Colorado Springs, CO 80919-2372. For more information please click here.

The UFC Anti-Doping Policy applies to UFC and its officials, employees and independent contractors, and each participant in aUFC Bout. It also applies to the following: Athletes, Athlete Support Personnel, and other Persons, each of whom is deemed, as a condition of his/her contract with UFC, license with any Athletic Commission, accreditation and/or participation in a UFC Bout or by the preparation of Athletes for participation in any UFC Bout, to have agreed to be bound by this Anti-Doping Policy, and to have submitted to the authority of UFC and USADA to enforce this Anti-Doping Policy and to have submitted to the jurisdiction of the hearing panel specified in Article 8 to hear and determine cases brought under this Anti-Doping Policy. More specifically, this Anti-Doping Policy shall apply to:

  1. All Athletes under contract with UFC from the date of their first contract until the earlier of the termination of their contract with UFC or such time as they give notice to UFC in writing of their retirement from competition; and
  2. All Athlete Support Personnel who: participate in any UFC Bout in any capacity, including without limitation as a manager, coach, trainer, second, corner man, agent, official, medical or paramedical personnel, or who have been identified by anAthlete to UFC or USADA as an Athlete Support Person.

Any Athlete, Athlete Support Personnel, or other Person who commits an Anti-Doping Policy Violation while subject to this Policy shall remain subject to this Policy for purposes of results management and discipline after the relationship which originally gave rise to UFC’s or USADA’s authority has ceased.

USADA’s education programs provide athletes, coaches and other interested individuals valuable information related to anti-doping including sample collection policies and procedures, prohibited substances, Therapeutic Use Exemptions, whereabouts requirements, athlete responsibilities, dietary supplements, and other related topics. Athletes can visit UFC.USADA.org/resources for education information and materials.

Testing

USADA conducts in-competition (IC) and out-of-competition (OOC) tests. OOC testing is conducted with individual athletes in an out-of-competition setting with little or no advance notice of the test. In-competition testing is generally conducted during or following an event. USADA collects both urine and blood samples as part of its program. USADA utilizes special analysis testing including, but not limited to, hGH and CIR testing, and collects additional data as part of the Athlete Biological Passport Program. For more information please click here.

For more information on sample collection, please click here.

USADA’s test distribution plan establishes the number of tests per sport based upon the number of athletes in the UFC Registered Testing Pool. Tests are allocated throughout the year at times when out-of-competition testing is most effective, and according to selection criteria.

USADA retains the right to test athletes at any time and location.

Any UFC athlete wishing to retire must promptly inform the UFC in writing. Under the UFC Anti-Doping Policy, any UFC athlete who has not provided advance written notice of retirement to the UFC and is notified for testing but refuses to provide a sample for an out-of-competition (OOC) test claiming retirement will be subject to all consequences consistent with an anti-doping policy violation (ADPV). For more information please click here.

Yes, USADA informs the athlete of all test results, including negative findings, and the UFC has access to information about all negative results.

In-Competition means the period commencing at noon on the day prior to the scheduled start of the fight card on which a bout is contested and ending upon the completion of the post-bout sample or specimen collection. If a post-bout sample or specimen collection is not initiated by USADA within a reasonable time, which will not exceed one hour following an athlete’s post-bout medical clearance, then the in-competition period shall expire at that time.

Out-of-competition refers to any period which is not in-competition.

Definitions for in-competition and out-of-competition are taken from the UFC Anti-Doping Policy.

Whereabouts

Athletes in the UFC Registered Testing Pool are required to submit their detailed location information, referred to as whereabouts, so that they can be located and available for out-of-competition, no-notice testing year-round. If an athlete is added to the UFC Registered Testing Pool (RTP) and is required to provide whereabouts information, they will be contacted by USADA.

As long as an athlete is enrolled in the USADA Registered Testing Pool (RTP), and is required to submit whereabouts, he or she must submit a Whereabouts Filing to USADA on a quarterly basis. Deadlines for submission are: December 15, March 15, June 15, and September 15. For more information on whereabouts, please click here.

Any time their schedules change from that which has previously been provided in the quarterly submission, an update should be submitted. There are many ways to conveniently provide updates. See next question for details.
Athletes may submit updates in several ways, including: online at UFC.USADA.org or through the Update USADA app, available through iTunes or the Google Play store.

Contact USADA via email at ufcathleteexpress@USADA.org or call us at 719.785.2000 (toll-free 1-866-601-2632 or International toll-free +8008-120-8120). We will walk you through the process of obtaining password information and utilizing the online system.

Yes. Upon the issuance of a third Whereabouts Failure within a rolling 12-month period, and before the determination that an Anti-Doping Policy Violation has occurred, an athlete may contest USADA’s decision to declare a Whereabouts Failure on any or all Whereabouts Failures to an independent administrative review panel within 14 days of the issuance of the third Whereabouts Failure.”  

Substances

The UFC Prohibited List identifies those prohibited substances and methods that are prohibited at all times (both in-competition and out-of-competition), as well as only during competition. The List is reviewed annually. You can find a full copy of the List here.

For information on prohibited substances, please click here. An athlete must check the UFC Prohibited List to determine what substances are prohibited, however, USADA also provides a number of drug reference resources to help athletes understand what substances are prohibited. To search if a specific medication is prohibited please visit UFC.GlobalDRO.com. Additionally, USADA provides a drug reference phone line, to speak to an expert.

Due to the current regulatory framework in the supplement industry, USADA is not able to tell athletes what dietary supplement products are safe to take. For more information on why, and to understand the risks associated with the use of dietary supplements, please visit our UFC Anti-Doping Policy supplement resource.

USADA provides prohibited status information on medication including prescription and over the counter brands through its Global DRO service; however this service does not apply to dietary supplement products. Due to the fact that supplements have been found to contain ingredients that are not listed on the label, and that there are an estimated 85,000+ dietary supplement products on the market without the type of pre-market approvals that drugs provide, it is impossible to determine with 100% accuracy whether a particular dietary supplement is safe to use, or free from prohibited substances. Detailed information about the dietary supplement marketplace can be found here.

Many dietary supplements may contain ingredients, including ones not listed on the label, that are prohibited. The only way to be 100 percent safe from supplements is to not use supplements.

USADA has always recommended that athletes use only dietary supplements that have been certified by a third-party program that tests for substances prohibited in sport. If athletes choose to use supplements despite the risks, it’s important to only use Certified Supplements, which are listed here and identified in the UFC Prohibited List.

 

The UFC Prohibited List incorporates the WADA Prohibited List. Even though Platelet Rich Plasma (PRP) contains some growth factors from your blood, WADA has clarified that PRP is not prohibited.  Individual growth factors are still prohibited when given separately or if they are added to any PRP treatment as purified substances as described on the Prohibited List Section S2.5.

Stem cell injections may or may not be prohibited, depending on how the cellular material is manipulated or modified for use. If the stem cells could or will cause performance enhancement, then the procedure is prohibited under either M1 Manipulation of Blood or Blood Components or M3 Gene Doping. How does an athlete know if stem cells cause performance enhancement? Since stem cell treatments vary widely, USADA needs detailed information to make this determination. If you are considering receiving stem cells as a part of any procedure, then please contact USADA on drugreference@USADA.org and provide detailed information about the procedure and origin of the stem cells.

Results Management

After receiving notification from the laboratory of an Adverse Analytical Finding or if USADA has decided to move forward with a non-analytical case (proof of a violation based upon evidence other than an adverse analytic finding), USADA will notify the athlete and the UFC. In a situation in which the ‘A’ sample has returned a positive result, the athlete will have the opportunity to be present for the ‘B’ sample opening.

The ‘B’ sample opening and analysis typically occur within 10 working days after the Adverse Analytical Finding report by the laboratory.

If the B sample confirms the A sample analysis, or the B sample analysis is not requested or is waived, the athlete shall be given notice of (a) the Anti-Doping Policy Violation asserted; (b) the basis of that assertion, (c) the additional information set forth in Article 14.1.3 of the UFC Anti-Doping Policy; (d) the consequences that will be imposed; (e) the athlete’s right, within 10 days of the notice, to request a hearing; and (f) that, if the athlete does not request a hearing within the time limit indicated, the consequences will be imposed immediately.  
The Anti-Doping Review Board generally meets within three weeks after a ‘B’ sample analysis confirms an Adverse Analytical Finding.

Yes. The athlete has the right to contest the sanction sought by USADA.

The athlete may elect to proceed to a hearing before an independent Arbitrator or potentially a three-arbitrator panel. The independent arbitrator/s will be selected from a pool of qualified arbitrators from McLaren Global Sport Solutions Inc. (MGSS).

For more information about the Arbitration Rules, click here.

Therapeutic Use Exemptions (TUEs)

For the UFC TUE FAQ area, please click here.
Scroll to Top